Antiviral Prophylaxis Against Hepatitis B Virus in Patients Treated with Anti-Tumor Necrosis Factor α Agents for Inflammatory Bowel Disease

참고문헌 (10)

1. 임선영, "The epidemiology of hepatitis B virus infection in Korea", The Korean Journal of Internal Medicine, 34(5), pp.945~953 (2019), 대한내과학회[DOI]
2. 김보현, "Epidemiology of liver cancer in South Korea", Clinical and Molecular Hepatology, 24(1), pp.1~9 (2018), 대한간학회
3. Young-Sun Lee, "Can More Aggressive Treatment Improve Prognosis in Patients with Hepatocellular Carcinoma? A Direct Comparison of the Hong Kong Liver Cancer and Barcelona Clinic Liver Cancer Algorithms", Gut and Liver, 12(1), pp.94~101 (2018), 거트앤리버 소화기연관학회협의회
4. 송은미, "Natural history of inflammatory bowel disease: a comparison between the East and the West", Intestinal research, 20(4), pp.418~430 (2022), 대한장연구학회[DOI]
5. Song Joo Hye, "Long-term Outcomes after the Discontinuation of Anti-Tumor Necrosis Factor-α Therapy in Patients with Inflammatory Bowel Disease under Clinical Remission: A Korean Association for the Study of Intestinal Disease Multicenter Study", Gut and Liver, 15(5), pp.752~762 (2021), 거트앤리버 소화기연관학회협의회[DOI]
6. 박상형, "Update on the epidemiology of inflammatory bowel disease in Asia: where are we now?", Intestinal research, 20(2), pp.159~164 (2022), 대한장연구학회[DOI]
7. Degasperi E, "Challenges in treating patients with inflammatory bowel disease and concurrent viral hepatitis infection", Expert Rev Gastroenterol Hepatol, 10, pp.1373~1383 (2016)
8. Soo-Kyung Park, "Prevention and management of viral hepatitis in inflammatory bowel disease: a clinical practice guideline by the Korean Association for the Study of Intestinal Diseases", Intestinal research, 18(1), pp.18~33 (2020), 대한장연구학회
9. Choon Jin Ooi, "Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohn’s disease in Asia", Intestinal research, 17(3), pp.285~310 (2019), 대한장연구학회[DOI]
10. Lee Ji Min, "Clinical Course of Hepatitis B Viral Infection in Patients Undergoing Anti-Tumor Necrosis Factor α Therapy for Inflammatory Bowel Disease", Gut and Liver, 16(3), pp.396~403 (2022), 거트앤리버 소화기연관학회협의회[DOI]